# Ventricular Assist Device Anti-Factor Xa (VAD ANTIX) Monitoring Study: a Prospective Randomized Feasibility Trial

> **NCT03143569** · NA · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 20 (actual)

## Conditions studied

- Left Sided Heart Failure
- Left Ventricular Assist Device
- Anticoagulant Therapy
- Gastro Intestinal Bleeding
- Thrombosis, LVAD
- Anti-factor Xa
- aPTT
- Heparin

## Interventions

- **DEVICE:** aPTT guided heparin management
- **DEVICE:** Anti-factor Xa guided heparin management

## Key facts

- **NCT ID:** NCT03143569
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-20
- **Primary completion:** 2018-07-12
- **Final completion:** 2018-07-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03143569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03143569, "Ventricular Assist Device Anti-Factor Xa (VAD ANTIX) Monitoring Study: a Prospective Randomized Feasibility Trial". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03143569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*